Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque®) [8]

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 376-378

  Laffitte, E ^a   Nenadov Beck, M ^a   Hofer, M ^a   Hohl, D ^a   Panizzon, R G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IOPENTOL;

BLISTER; CANCER LOCALIZATION; CASE REPORT; CHEILITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; ERYTHEMA; HODGKIN DISEASE; HUMAN; LETTER; LYMPHADENOPATHY; MALE; PAPULE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; STEVENS JOHNSON SYNDROME;

CHILD; CONTRAST MEDIA; DRUG ERUPTIONS; HUMANS; MALE; STEVENS-JOHNSON SYNDROME; TRIIODOBENZOIC ACIDS;

EID: 1542402019     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05763.x     Document Type: Letter

References (13)

1. Leaute-Labreze C, Lamireau T, Chawki D et al. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83: 347-52.
2. Savill JS, Barrie R, Ghosh S et al. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J 1988; 64: 392-4.
3. Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 1998; 53: 1221-4.
4. Watanabe H, Sueki H, Nakada T et al. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium. Dermatology 1999; 198: 291-4.
5. Hosoya T, Yamaguchi K, Akutsu T et al. Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 2000; 18: 39-45.
6. Kaftori JK, Abraham Z, Gilhar A. Toxic epidermal necrolysis after excretory pyelography. Immunologic-mediated contrast medium reaction? Int J Dermatol 1988; 27: 346-7.
7. Rosado A, Canto G, Veleiro B, Rodriguez J. Toxic epidermal necrolysis after repeated injections of iohexol. Am J Roentgenol 2001; 176: 262-3.
8. Buttoni U, Pulsoni A, Innocenzi D et al. Toxic epidermal necrolyis (TEN) in a patient with non-Hodgkin lymphoma: successful treatment with dexamethasone at high dosage. J Eur Acad Dermatol Venereol 2000; 14: 140-2.
9. Muth CP, Henseke P, Grynne BH. Iopentol (Imagopaque) in vascular procedures. A multi-centre monitoring trial assessing adverse events and diagnostic information - results from 3,587 patients in Germany. Eur Radiol 1997; 7: S104-8.
10. Bohn S, Hurni M, Bircher AJ. Contact allergy to trometamol. Contact Dermatitis 2001; 44: 319.
11. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23: 1039-58.
12. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 2000; 10: 1965-75.
13. Wolkenstein P, Chosidow O, Flechet ML et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-6.